Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Change in Cash (2016 - 2025)

Theravance Biopharma has reported Change in Cash over the past 12 years, most recently at -$7.0 million for Q4 2025.

  • Quarterly Change in Cash fell 148.32% to -$7.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $130.0 million through Dec 2025, up 7537.59% year-over-year, with the annual reading at $130.0 million for FY2025, 7537.59% up from the prior year.
  • Change in Cash was -$7.0 million for Q4 2025 at Theravance Biopharma, up from -$107.2 million in the prior quarter.
  • Over five years, Change in Cash peaked at $331.2 million in Q3 2022 and troughed at -$120.4 million in Q4 2022.
  • The 5-year median for Change in Cash is -$7.3 million (2022), against an average of $4.3 million.
  • Year-over-year, Change in Cash plummeted 2607.53% in 2023 and then skyrocketed 2387.22% in 2025.
  • A 5-year view of Change in Cash shows it stood at -$31.5 million in 2021, then plummeted by 282.59% to -$120.4 million in 2022, then skyrocketed by 73.3% to -$32.1 million in 2023, then soared by 144.86% to $14.4 million in 2024, then tumbled by 148.32% to -$7.0 million in 2025.
  • Per Business Quant, the three most recent readings for TBPH's Change in Cash are -$7.0 million (Q4 2025), -$107.2 million (Q3 2025), and $171.3 million (Q2 2025).